$AVD

Kaye Douglas purchased $12K of AVD

Kaye Douglas (CHIEF EXECUTIVE OFFICER) purchased 5,000 shares of AMERICAN VANGUARD CORP (AVD) at $2.50 on 2026-06-03.

Original reporting
SEC EDGAR · Kaye Douglas
Published Jun 8, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVD
Bullish
medium confidence
Mentioned
$AVD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVDBullishLow
01

Why it matters

The newest concrete fact is the CEO’s direct open-market purchase of 5,000 shares at $2.50, with post-transaction holdings of 300,251 shares.

02

Market read

This provides a small, primary-source bullish datapoint (insider buying) but lacks any operational or guidance catalyst.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan; traders may still discount the signal because the disclosed purchase value is small versus typical market-moving thresholds.

Relevance 4/10Novelty 2/10Timing: Filed 2026-06-08; transaction dated 2026-06-03.

Background

The filing is an SEC Form 4 insider transaction for American Vanguard Corp, reported via SEC EDGAR.

Company-level read

Ticker impact

$AVDBullishMedium confidence
Context

SEC Form 4 shows CEO Kaye Douglas bought 5,000 shares of American Vanguard at $2.50 on 2026-06-03 (direct open-market purchase).

Expected impact

Low near-term impact; any effect is likely sentiment-driven rather than fundamental.

Evidence & confidence

The article is a primary insider transaction disclosure with small dollar value and no accompanying company-specific operational/regulatory catalyst.

Market effects

No sector read-through; this is a single-company insider transaction with limited scale.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, liquidity needs, or routine compensation-related behavior rather than a strong forward outlook.

Key entities

  • American Vanguard Corp

    Subject of the insider transaction disclosure (AVD).

  • Kaye Douglas

    Chief Executive Officer who reported the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AVDMed

American Vanguard Corporation Q2 2026 Earnings Call Summary

American Vanguard reported a 10% quarterly revenue decline, driven by an 18% drop in international sales tied to Super El Nino weather and inflation in Central America and Mexico. Management cited improved gross margins (+100 bps in 1H 2026) and expects Los Angeles facility rationalization savings of at least $4M. 2026 guidance: $44M-$48M adjusted EBITDA on $530M-$550M sales.

$AVDMed

AMERICAN VANGUARD CORP (AVD): Results of Operations and Financial Condition

AMERICAN VANGUARD CORP (AVD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE American Vanguard Reports Second Quarter 2026 Results First-Half Gross Profit Increased 3%, and EBITDA Increased 21% on Mostly Flat Sales Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 mil

$AVDMedAI 8/10

American Vanguard (AVD) Q2 2026 Earnings Call Transcript

American Vanguard (AVD) reported Q2 2026 net sales of $117 million, down from $129 million in Q2 2025. International sales fell 18% in the quarter, while specialty revenue rose 11%. Adjusted EBITDA was $0.6 million versus $11 million a year earlier. 2026 guidance calls for revenue of $530 million to $550 million and adjusted EBITDA of $44 million to $48 million.

$AVDMedAI 8/10

American Vanguard Reports Second Quarter 2026 Results

American Vanguard Corporation reported Q2 2026 net sales of $117 million versus $129 million in Q2 2025, with gross margin at 30% versus 31%. The company posted an operating loss of $0.30 million and net loss of $9.9 million. Adjusted EBITDA was $6.6 million. For 2026, it reaffirmed guidance of adjusted EBITDA $44 million to $48 million on sales of $530 million to $550 million.